Stereotaxis Inc Stock Nasdaq
Stocks
US85916J4094
Advanced Medical Equipment & Technology
| Market Cap | 154M 135M 124M 115M 216M 14.84B 221M 1.49B 584M 7.27B 579M 566M 25.02B | P/E 2026 * |
-7.75x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 154M 135M 124M 115M 216M 14.84B 221M 1.49B 584M 7.27B 579M 566M 25.02B | EV / Sales 2026 * |
3.91x | EV / Sales 2027 * | 2.89x |
| Free-Float |
84.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stereotaxis Inc
| 1 day | -7.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischel
CEO | Chief Executive Officer | - | 03/02/2017 |
Kimberly Peery
DFI | Director of Finance/CFO | 57 | 01/10/2019 |
Keith Galloway
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Fischel
CHM | Chairman | - | 03/02/2017 |
Nathan Fischel
BRD | Director/Board Member | 70 | 03/02/2017 |
Arun Menawat
BRD | Director/Board Member | 71 | 29/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.43% | -2.84% | - | - | 154M | |
| -1.97% | +1.03% | +28.39% | -0.57% | 198B | |
| -0.58% | +2.40% | +7.25% | -16.42% | 144B | |
| -14.15% | -15.08% | -33.40% | -1.22% | 122B | |
| -1.32% | -1.65% | -57.52% | -15.88% | 65.44B | |
| -2.40% | -7.03% | +12.08% | -6.43% | 49.36B | |
| +0.07% | -1.29% | -23.36% | -31.63% | 44.74B | |
| -3.41% | -2.11% | +15.33% | +6.81% | 37.13B | |
| -2.44% | -1.98% | +28.33% | +31.74% | 36.23B | |
| -1.86% | -2.39% | -22.85% | -8.74% | 28.7B | |
| Average | -3.55% | -2.81% | -5.08% | -4.71% | 80.68B | |
| Weighted average by Cap. | -3.68% | -2.62% | -0.96% | -5.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.4M 34.43M 31.77M 29.29M 55.2M 3.79B 56.42M 380M 149M 1.86B 148M 145M 6.4B | 53.28M 46.56M 42.96M 39.6M 74.64M 5.13B 76.3M 513M 202M 2.51B 200M 196M 8.65B |
| Net income | -19.4M -16.95M -15.64M -14.42M -27.18M -1.87B -27.78M -187M -73.55M -915M -72.86M -71.26M -3.15B | -13.62M -11.91M -10.99M -10.13M -19.09M -1.31B -19.51M -131M -51.65M -643M -51.17M -50.05M -2.21B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
